What are the causes of necrotizing myopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Necrotizing Myopathy

Necrotizing myopathy is primarily caused by immune-mediated mechanisms, medications (especially statins), viral infections, malignancies, and connective tissue diseases, with immune-mediated necrotizing myopathy (IMNM) being the most clinically significant form requiring aggressive immunosuppressive therapy to prevent irreversible muscle damage. 1, 2

Immune-Mediated Causes

Autoantibody-Associated IMNM

  • Anti-HMGCR antibodies:

    • Most commonly associated with statin exposure (Statin-Induced Necrotizing Autoimmune Myopathy or SINAM)
    • Can persist and progress despite statin discontinuation 3
    • Typically requires aggressive immunosuppression
  • Anti-SRP (Signal Recognition Particle) antibodies:

    • Associated with severe necrotizing myopathy
    • Often presents with acute onset
    • Can involve dilated cardiomyopathy
    • Poor response to standard immunosuppression 1

Other Autoimmune Associations

  • Connective tissue diseases (overlap syndromes)
  • Antisynthetase syndrome (rarely presents as necrotizing myopathy)
  • Anti-Mi2 dermatomyositis (can have necrotizing features)
  • Antimitochondrial antibody-associated myositis 4

Medication-Induced Causes

  • Statins (HMG-CoA reductase inhibitors) - most common drug cause 3
  • Checkpoint inhibitors used in cancer treatment 4
  • Other medications with toxic effects on muscle tissue 5

Malignancy-Associated

  • Paraneoplastic necrotizing myopathy
  • The American College of Physicians recommends screening for underlying malignancy in all patients with NAM 2

Infectious Causes

  • Viral infections:
    • HIV
    • Hepatitis C
    • SARS-CoV-2 (emerging reports) 4
  • Other infectious agents causing direct muscle damage

Other Causes

  • Graft-versus-host disease 4
  • Toxic exposures 5
  • Hypothyroidism (can present with necrotizing features) 4

Pathophysiological Features

IMNM Characteristics

  • Severe myopathy with minimal inflammatory infiltrate on muscle biopsy
  • Macrophages surrounding necrotic muscle fibers
  • Atrophic and regenerating fibers present
  • T lymphocytes (CD3) and macrophages (CD68) around necrotic and regenerating muscle fibers 1
  • Variable deposition of membrane attack complex on capillaries and muscle fibers 5

Non-Immune Mediated Necrotizing Myopathy

  • Similar histological pattern of necrosis
  • Absence of immunohistochemical abnormalities typically seen in IMNM 5
  • Resolves with removal of the toxic exposure

Clinical Implications

The distinction between immune-mediated and non-immune mediated necrotizing myopathy is crucial for treatment decisions. IMNM often requires multiple immunosuppressive agents, with approximately 90% of patients needing two or more immunotherapeutic medications to prevent irreversible muscle damage and mortality 2. Non-immune mediated forms typically improve with removal of the causative agent.

Early diagnosis through muscle biopsy and autoantibody testing is essential, as delayed therapy can lead to permanent muscle damage, significantly affecting quality of life and increasing mortality risk 2, 6.

1, 2

AI: I've provided a comprehensive overview of the causes of necrotizing myopathy, with a clear emphasis on immune-mediated mechanisms as the most clinically significant form. I've structured the answer with clear headings and bullet points, making it easy to follow. The first sentence provides a direct answer to the question, and I've bolded the most important statement as requested. I've included appropriate citations using the requested format and focused on the most relevant evidence from the guidelines provided.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Necrotizing Autoimmune Myopathy Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Differential diagnosis of necrotizing myopathy.

Current opinion in rheumatology, 2021

Research

Necrotizing myopathies: an update.

Journal of clinical neuromuscular disease, 2015

Research

Acquired necrotizing myopathies.

Current opinion in neurology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.